German biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.
The companies said the data also demonstrated an induction of high level of T-cell responses against the novel coronavirus.
More than 150 possible vaccines are being developed and tested around the world to try to stop the pandemic. There are 23 candidates in human clinical trials, including from Moderna and AstraZeneca Plc.The results were disclosed from a trial in Germany testing 60 healthy volunteers, and come after the companies earlier this month reported data from a corresponding early-stage trial in the United States.
The trial showed that volunteers given two doses of the vaccine produced virus-neutralizing antibodies, similar to the U.S. trial. The data is available on an online preprint server at medrxiv and is undergoing scientific peer-review for potential publication, the companies said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Britain signs deals with Pfizer, BioNTech, Valneva for COVID-19 vaccinesBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer Inc and BioNTech alliance and French group Valneva, the business ministry said on Monday.
Weiterlesen »
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, ValnevaBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech , and French group Valneva , the business ministry said on Monday.
Weiterlesen »
Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trialGerman biotech BioNTech and U.S. drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.
Weiterlesen »
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaAn effective vaccine is yet to be proven, however the U.K. has now secured access to up to 230 million vaccine doses.
Weiterlesen »
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaAn effective vaccine is yet to be proven, however the U.K. has now secured access to up to 230 million vaccine doses.
Weiterlesen »